Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1064/532nm), cryotherapy and chemical peels: A comparative study. - Trial PACTR201811835577312
Access comprehensive clinical trial information for PACTR201811835577312 through Pure Global AI's free database. This Phase 4 trial is sponsored by Sarah Ibrahim and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sarah Ibrahim
Sarah Ibrahim Ismail
Timeline & Enrollment
Phase 4
Jun 25, 2017
Mar 25, 2018
Summary
The face and neck were chosen to verify the possibility of introducing TCA peels, 25 and 50%, as depigmenting agents and compare their efficacy with QS Nd:YAG laser (532 and 1064 nm) in depigmentation for vitiligo cases with undesired residual pigmented. The upper limb was chosen to evaluate and compare the effectiveness of phenol peel 88%, cryotherapy and QS Nd:YAG (532 and 1064 nm) laser in depigmentation of remaining normal-colored.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201811835577312
Non-Device Trial